Therapeutic applications of melatonin and related compounds

Hormone Research

Volumn 49, Issue 3-4, 1998, Pages 142-146

  Defrance, R ^a   Quera Salva, M A ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Aging; Blindness; Circadian rhythms; Delayed sleep phase syndrome; Insomnia; Melatonin; Sleep; Suprachiasmatic nucleus

Indexed keywords

BENZODIAZEPINE DERIVATIVE; MELATONIN; MELATONIN RECEPTOR; RECEPTOR SUBTYPE;

CIRCADIAN RHYTHM; CLINICAL TRIAL; CONFERENCE PAPER; CORE TEMPERATURE; DRUG CLEARANCE; DRUG EFFECT; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; INSOMNIA; JET LAG; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SLEEP DISORDER; SLEEP INDUCTION; SLEEP PATTERN; SOMNOLENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; HUMANS; MELATONIN; SLEEP DISORDERS;

EID: 0031931211     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023161     Document Type: Conference Paper

References (55)

1. Moore RY: Organization of the primate circadian system. J Biol Rhythms 1993;8:S3-S9.
2. Hastings MH: Neuroendocrine rhythms. Pharmacol Ther 1991;50:35-71.
3. Edgar DM, Dement WC, Fuller CA: Effect of SCN lesions on sleep in squirrel monkeys: Evidence for opponent processes in sleep-wake regulation. J Neurosci 1993;13:1065-1079.
4. Weaver DR, Stehle JH, Stopa EG, Reppert SM: Melatonin receptors in human hypothalamus and pituitary: Implications for circadian and reproductive responses to melatonin. J Clin Endocrinol Metab 1993;76:295-301.
5. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenmaupt SA, Gusella GF: Characterization of a second melatonin expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995;92: 8734-8738.
6. Ying SW, Rusak B, Delagrange P, Mocaer E, Renard P, Guardiola-Lemaitre B: Melatonin analogues as agonists and antagonists in the circadian system and other brain areas. Eur J Pharmacol 1996;296:33-42.
7. McArthur AJ, Hunt AE, Gillette MU: Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: Activation of proteine kinase C at dusk and dawn. Endocrinology 1997;138:627-634.
8. Lewy AJ, Ahmed S, Latham Jackson JM, Sack RL: Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 1992;9:380-392.
9. Zaidan R, Geoffriau M, Brun J, Taillard J, Bureau C, Chazot G, Claustrat B: Melatonin is able to influence its secretion in humans: Description of a phase-response curve. Neuroendocrinology 1994;60:105-112.
10. Armstrong SM, McNulty OM, Guardiola-Lemaitre B, Redman JR: Successful use of S20098, a melatonin agonist in an animal model of delayed sleep phase syndrome. Pharmacol Biochem Behav 1993;46:45-49.
11. Martient L, Guardiola-Lemaitre B, Mocaer E: Entrainment of circadian rhythms by S20098, a melatonin agonist, is dose and plasma concentration dependent. Pharmacol Biochem Behav 1996;54:713-718.
12. Arendt J: Target sites and mechanism of action of melatonin; in Arendt J (ed): Melatonin and the Mammalian Pineal Gland. London, Chapman & Hall, 1995, pp 291-317.
13. Tobler I, Jaggi K, Borbely AA: Effects of melatonin and the melatonin receptor agonist S20098 on the vigilance states. EEG spectra and cortical temperature in the rat. J Pineal Res 1994;16:26-32.
14. Dawson D, Encel N: Melatonin and sleep in humans. J Pineal Res 1993;15:1-12.
15. Zhdanova IV, Wurtman RJ, Morabito C, Piotrovska VR, Lynch HJ: Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans. Sleep 1996;19:423-431.
16. Attenburrow MEJ, Cowen PJ, Sharpley AL: Low-dose melatonin improves sleep in healthy middle-aged subjects. Psychopharmacology 1996;126:179-181.
17. James SP, Mendelson WB, Sack DA, Rosenthal NE, Wehr TA: The effect of melatonin on normal sleep. Neuropsychopharmacology 1987;1:41-44.
18. Lehmann ED, Cockerell OC, Rudge P: Somnolence associated with melatonin deficiency after pinealectomy. Lancet 1996;347:323.
19. Middleton BA, Stone BM, Arendt J: Melatonin and fragmented sleep patterns. Lancet 1996; 348:551-552.
20. Nave R, Herer P, Haimov I, Shlitner A, Lavie P: Hypnotic and hypothermie effects of melatonin on daytime sleep in humans: Lack of antagonism by flumazenil. Neurosci Lett 1996; 214:123-126.
21. Cagnacci A, Elliott JA, Yen SSC: Melatonin: A major regulator of the circadian rhythm of core temperature in humans. J Clin Endocrinol Metab 1992;75:447-452.
22. Deacon S, Arendt J: Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in dose-dependet manner in humans. Brain Res 1995;688:77-85.
23. Attenburrow MEJ, Dowling BA, Sargent PA, Sharpley AL, Cowen PJ: Melatonin phase advances circadian rhythm. Psychopharmacology 1995;121:503-505.
24. Tzischinsky O, Lavie P: Melatonin possesses time-dependent hypnotic effects. Sleep 1994; 17:638-645.
25. Dawson D, Armstrong SM: Chronobiotics: Drugs that shift rhythms. Pharmacol Ther 1996;69:15-36.
26. Satinoff E, Li H, Tcheng TK, Liu C, McArthur AJ, Medanic M, Gillette MU: Do the suprachiasmatic nuclei oscillate in old rats as they do in young ones? Am J Physiol 1993;265:1216-1222.
27. Sutin EL, Dement WC, Heller HC, Kilduff TS: Light-induced gene expression in the suprachiasmatic nucleus of young and aging rats. Neurobiol Aging 1993;14:441-446.
28. Turek FW, Penev P, Zhang Y, Vanreeth O, Takahashi JS, Zee P: Alterations in the circadian system in advanced age. Ciba Found Symp 1995;183:212-226.
29. Myers BL, Badia P: Changes in circadian rhythms and sleep quality with aging: Mechanisms and interventions. Neurosci Biobehav Rev 1995;19:553-571.
30. Moe KE, Vitiello MV, Larsen LH, Prinz PN: Sleep/wake patterns in Alzheimer's disease: Relationships with cognition and function. J Sleep Res 1995;4:15-20.
31. Waldhauser F, Weiszenbacher G, Tatzer E, Gisinger B, Waldhauser M, Schemper M, Frisch H: Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 1988;66:648-652.
32. Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Shlitner A, Herer P, Tzischinsky O, Lavie P: Sleep disorders and melatonin rhythms in elderly people. BMJ 1994;309:167.
33. Garfinkel D, Laudon M, Nof D, Zisapel NE: Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995; 346:541-544.
34. Haimov I, Lavie P: Potential of melatonin -replacement therapy in older patients with sleep disorders. Drug Aging 1995;7:75-78.
35. Wurtman RJ, Zhdanova I: Improvement of sleep quality by melatonin. Lancet 1995;346: 1491.
36. Ellis CM, Lemmens G, Parkes JD: Melatonin and insomnia. J Sleep Res 1996;5:61-65.
37. Leger D, Guillemmault C, Defrance R, Domont A, Paillard M: Blindness and sleep patterns. Lancet 1996;348:830-831.
38. Czeisler CA, Shanahan TL, Klerman EB, Martens H, Brotman DJ, Emens JS, Klein T, Rizzo III JF: Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med 1995;332:6-11.
39. Sack RL, Lewy AJ, Blood ML, Keith LD, Nakagawa H: Orcadian rhythm abnormalities in totally blind people: Incidence and clinical significance. J Clin Endocrinol Metab 1992;75: 127-134.
40. Tzischinsky O, Pal I, Epstein R, Dagan Y, Lavie P: The importance of timing in melatonin administration in a blind man. J Pineal Res 1992;12:105-108.
41. Sack RL, Lewy AJ, Blood ML, Stevenson J, Donald Keith L: Melatonin administration to blind people: Phase advances and entrainment. J Biol Rhythms 1991;6:249-261.
42. Palm L, Blennow G, Wetterberg L: Correction of non-24-hour sleep/wake cycle by melatonin in a blind retarded boy. Ann Neurol 1991;29: 336-339.
43. Arendt J, Aldhous M, Wright J: Synchronisation of a disturbed sleep-wake cycle in a blind man by melatonin treatment. Lancet 1988;i: 772-773.
44. Stores G: Sleep studies in children with a mental handicap. J Child Psychol Psychiatry 1992; 33:1303-1317.
45. Jan JE, O Donnell ME: Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res 1996;21:193-199.
46. Camfield P, Gordon K, Dooley J, Camfield C: Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six 'N of 1' trials. J Child Neurol 1996;11:341-343.
47. Dahlitz M, Alvarez B, Vignau J, English J, Arendt J, Parkes JD: Delayed sleep phase syndrome response to melatonin. Lancet 1991; 337:1121-1124.
48. Claustrat B, Brun J, David M, Sassolas G, Chazot G: Melatonin and jet-lag: Confirmatory result using a simplified protocol. Biol Psychiatry 1992;32:705-711.
49. Arendt J, Aldhous M, English J, Marks V, Arendt JH, Marks M, Folkard S: The effects of jet-lag and their alleviation by melatonin. Ergonomics 1987;30:1379-1393.
50. Dawson D, Encel N, Lushington K: Shift work and sleep deprivation. Improving adaptation to simulated night shift: Timed exposure to bright versus daytime melatonin administration. Sleep 1995;18:11-21.
51. Brown GM: Melatonin in Psychiatric and Sleep Disorders - Therapeutic Implications. CNS Drugs 1995;3:209-226.
52. Brzezinski A: Melatonin in humans. N Engl J Med 1997;336:186-195.
53. Di WL, Kadva A, Johnston A, Silman R: Variable biovailability of melatonin. N Engl J Med 1997;336:1028-1029.
54. Reiter RJ: The pineal and its hormones in the control of reproduction in mammals. Endocr Rev 1980;1:109-131.
55. Osata M, Bulur M, Bingol N, Beyhan Z, Corakci A, Bolu E, Gundogan MA: Daytime plasma melatonin levels in male hypogonadism. J Clin Endocrinol Metab 1996;81:1877-1881.